Navigation Links
Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
Date:7/15/2009

e Commission filings, including Part II, Item 1A. "Risk Factors" in the Company's first quarter 2009 10-Q, filed May 1, 2009.

Endnotes

1 Hoffmann C (2007) The epidemiology of HIV coreceptor tropism. Eur J Med Res (2007) 12: 385-390.

2 Atazanavir sulfate is a Bristol-Myers Squibb Company prescription medicine. Please see the atazanavir product insert for information on this product.

3 Truvada is a registered trademark of Gilead Sciences, Inc. Please see the Truvada product insert for information on this product.

4 Hammer SM, Schechter M, Montaner JS, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006; 296: 827-43.

5 Data collection on adverse events of anti-HIV drugs (DAD) study group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993-2003.

6 The DAD study group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356: 1723-35.

7 The DAD study group. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the DAD study: a multi-cohort collaboration. www.thelancet.com published online April 2, 2008, DOI:10.1016/S0140-6736(08)60423-7.

8 Dunkle LM, Greaves WL, et al. Long-Term Safety of Vicriviroc. 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th Annual Meeting; Oct. 25-28, 2008; Washington, D.C., USA; No. H-1269.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
2. Schering-Plough Announces Results of the Early ACS Trial
3. Schering-Ploughs Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
4. Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
5. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
6. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
7. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
8. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
9. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
10. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... MOUNTAIN VIEW, Calif. , July 22, 2014 ... magnetic resonance imaging (MRI) market, Frost & Sullivan ... Award for Product Leadership. Siemens Healthcare,s FREEZEit solution, ... addresses the need for robust and motion-insensitive imaging. ... has boosted the evolution of body MRI imaging ...
(Date:7/22/2014)... England , July 22, 2014 Elekta ... announced today that The Christie NHS Foundation Trust ( ... will join a consortium whose mission is to develop ... (MRI) guided radiation therapy system. Such a system would, ... visualization of cancer targets. "The Christie ...
(Date:7/22/2014)... Ariz. , July 22, 2014  A ... of a SynCardia temporary Total Artificial ... Rochester,s Strong Memorial Hospital with the Freedom® portable ... Fontana, a 64-year-old retiree from a ... decades. He managed the condition with medications, an ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
(Date:7/22/2014)... CyraCom has been ranked as North America’s 6th largest ... industry. Released June 2014 by the market research firm ... Market: 2014," also ranked CyraCom as the 18th ... from 2013. , In 2013, Common Sense Advisory also ... – a subset of the language service industry. CyraCom ...
(Date:7/22/2014)... New York (PRWEB) July 22, 2014 ... new market report based on Molecular Diagnostics Market – ... to 2019 in addition to their comprehensive database. This ... market for clinical applications. It is valued at USD ... a CAGR of 11.1% from 2013 to 2019. Molecular ...
(Date:7/22/2014)... 22, 2014 University of the ... opened the doors of its state-of-the-art, $151 million campus ... heart of downtown San Francisco's South of Market (SoMa) ... a year. Those patients will now be greeted by ... iKiosks . , Advanced Kiosks engineering team designed ...
(Date:7/22/2014)... Investigators at the Cedars-Sinai Samuel Oschin Comprehensive Cancer ... for one of the most complex and difficult-to-treat ... , Locally advanced pancreatic cancer has the ... a cumulative five-year survival rate of only 4 ... rarely an option for patients because tumors often ...
(Date:7/22/2014)... SkillSurvey Inc., the leading provider ... make better hiring decisions, will be delivering a ... engagement and retention of contingent workers at the ... Conference being held in Orlando, Florida on July ... study featuring Metro Health, a hospital in Grand ...
Breaking Medicine News(10 mins):Health News:CyraCom Ranked Among the World’s Largest Language Service Providers 2Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 2Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 3Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 4Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 2Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 3Health News:SkillSurvey to Present Research on Contingent Workers at National Association for Health Care Recruitment IMAGE 2014 Conference 2
... can determine the gentleness of a surgeon while performing a ... and colleague//. ,The invention of Dr Vijay Maker, ... and Dr Joseph Talarico, a surgical resident at the same ... development. While the original idea is Maker's, Talarico designed the ...
... is time for impatient patients to travel abroad rather than ... ailments. Recently, a woman won the right to claim compensation ... In yet another case, a 63-year-old British woman who traveled ... confirmed absence of any genetic disorder. ,A recent ...
... in Japan has found migraine medication sumatriptan, known by ... for pain// due to trigeminal neuralgia up to eight ... migraine medication could provide relief for people who suffer ... found it produced rapid and significant pain relief without ...
... Tamil Nadu Hindu Religious and Charitable Endowment Minister P T ... a train and died at a private hospital at Dindigul ... from the Madurai Central Constituency, was also the speaker of ... survived by his wife Rukmani and a son, who is ...
... is found that there is an increase in number of ... action// to tackle young criminals. According to the statistics the ... criminal offences due to alcohol increased by more than 150 ... crimes and theft. But the figures of the number of ...
... Indiana University Bloomington have reported that mouse sperm cells ... cells were bang on target, even when ovary extracts ... exhibit chemotaxis toward extracts from various female reproductive organs, ... known," said IUB Associate Professor of Chemistry Stephen C. ...
Cached Medicine News:Health News:Study Finds That Migraine Drug Can Ease The Severest Of Facial Pain 2Health News:Sperm Cells attracted By Ovary Scent, Even in Weakened State 2
... In certain hernia and soft tissue ... fascial defects, it is sometimes necessary ... one surface, while minimizing tissue attachment ... a soft, conformable, ePTFE sheet material ...
... Bard Dulex mesh is a dual-sided ePTFE ... side is a micro-porous structure designed to minimize ... side is a macro-porous structure designed to promote ... size of approximately 800 microns, which is nearly ...
... mesh is the first polypropylene mesh ... Visilex mesh directly addresses the critical ... specifically, it delivers maximum visibility, enhanced ... after insertion through the trocar.,Visilex mesh ...
... is constructed of knitted filaments of ... that used in PROLENE* Polypropylene Suture, ... The mesh is approximately,0.020 inches thick. ... suture, has been reported to be ...
Medicine Products: